InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.640
-0.015 (-0.91%)
Feb 21, 2025, 4:00 PM EST - Market closed
InterCure Employees
InterCure had 270 employees as of December 31, 2023. The number of employees decreased by 100 or -27.03% compared to the previous year.
Employees
270
Change (1Y)
-100
Growth (1Y)
-27.03%
Revenue / Employee
$268,226
Profits / Employee
-$64,553
Market Cap
78.89M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 270 | -100 | -27.03% |
Dec 31, 2022 | 370 | 20 | 5.71% |
Dec 31, 2021 | 350 | 275 | 366.67% |
Dec 31, 2020 | 75 | 0 | - |
Dec 31, 2019 | 75 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
INCR News
- 10 days ago - InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - PRNewsWire
- 2 months ago - InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PRNewsWire
- 5 months ago - Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
- 6 months ago - InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewsWire
- 6 months ago - InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire
- 8 months ago - InterCure: A Cannabis Industry Leader Still Flying Under The Radar - Seeking Alpha
- 9 months ago - InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference - Business Wire
- 10 months ago - InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire